FertilAI, a pioneering healthcare company based in Israel, has recently announced an impressive funding round of $4.5 million, a significant boost to its mission of transforming fertility treatment outcomes for patients and clinics alike. Founded by a visionary team that includes esteemed technology experts and renowned reproductive endocrinologists such as Prof. Ariel Hourvitz, Dr. Ettie Maman, and Dr. Micha Baum, FertilAI is at the forefront of leveraging artificial intelligence to enhance fertility treatment success rates. The newly acquired funds will be primarily allocated towards the further development of its innovative Fertilane platform, which integrates sophisticated AI algorithms that empower physicians to make informed clinical decisions throughout the treatment process. By automating critical aspects of fertility care, FertilAI not only elevates the patient experience by ensuring timely and personalized communication but also equips clinics with the tools needed to effectively scale their operations. The Fertilane platform features tailored doctor/patient applications and administrative web apps designed specifically for the nuanced workflows within fertility clinics, thereby streamlining processes and enhancing collaboration. With this latest infusion of capital, FertilAI is poised to expand its reach, accelerate the development of cutting-edge technologies, and ultimately improve the lives of countless individuals seeking fertility treatments. This funding marks a significant step forward in FertilAI’s commitment to revolutionizing the fertility landscape, making advanced treatments more accessible and effective for patients everywhere.
FertilAI Secures $4.5M in Seed Funding to Empower Fertility Treatment Success with Cutting-Edge AI Technology
Recently funded · $4.5M SeedHealthcare
Get the full FertilAI company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
Other recent Seed rounds
Companies that recently closed a Seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  DIMENSION United States | Seed | $1.6M | today |
| 2 |  Dimension Studios United States | Seed | $1.6M | today |
